The comparison of the efficacy and safety of cetirizine, oxatomide, ketotifen, and a placebo for the treatment of childhood perennial allergic rhinitis
Authors:
- Ko-Huang LueKLKo-Huang Lue
- 1 December 2002
- journal article
- clinical trial
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 89 (6) , 589-598
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Long-term cetirizine treatment reduces allergic symptoms and drug prescriptions in children with mite allergyAnnals of Allergy, Asthma & Immunology, 2001
- Subjective and objective markers of treatment response in patients with seasonal allergic rhinitisAnnals of Allergy, Asthma & Immunology, 2000
- Ketotifen for asthma in children aged 5 to 15 years: a randomized placebo-controlled trialAnnals of Allergy, Asthma & Immunology, 2000
- H1-receptor antagonists: safety issuesAnnals of Allergy, Asthma & Immunology, 1999
- Comparative Study of Cetirizine and Terfenadine Versus Placebo in the Symptomatic Management of Seasonal Allergic RhinitisAnnals of Allergy, Asthma & Immunology, 1996
- Cetirizine inhibits the in vitro and ex vivo chemotactic response of T lymphocytes and monocytesJournal of Allergy and Clinical Immunology, 1995
- Inhibition of mediator release in RBL-2H3 cells by some H1-antagonist derived anti-allergic drugs: Relation to lipophilicity and membrane effectsInflammation Research, 1995
- In vitro effects of H1‐antihistamines on histamine and PGD2 release from mast cells of human lung, tonsil, and skinAllergy, 1994
- Allergen-induced increase in nonspecific nasal reactivity is blocked by antihistamines without a clear-cut relationship to eosinophil influxJournal of Allergy and Clinical Immunology, 1990
- Assessing degree of nasal patency by measuring peak expiratory flow rate through the noseJournal of Allergy and Clinical Immunology, 1973